Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors

Details for Australian Patent Application No. 2002258631 (hide)

Owner New York University

Inventors Meruelo, Daniel

Agent Davies Collison Cave

Pub. Number AU-B-2002258631

PCT Pub. Number WO2002/076468

Priority 60/279,051 27.03.01 US; 60/311,373 10.08.01 US

Filing date 27 March 2002

Wipo publication date 8 October 2002

Acceptance publication date 17 May 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 38/20 (2006.01) Medicinal preparations containing peptides - Interleukins

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 1/18 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 13/00 (2006.01) Drugs for disorders of the urinary system

A61P 13/08 (2006.01) Drugs for disorders of the urinary system

A61P 13/12 (2006.01) Drugs for disorders of the urinary system

A61P 15/00 (2006.01) Drugs for genital or sexual disorders

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

Event Publications

27 March 2003 Application Open to Public Inspection

  Published as AU-B-2002258631

17 May 2007 Application Accepted

  Published as AU-B-2002258631

13 September 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002258632-PYRROLIDINE SULFONAMIDES

2002258630-ISOLATED HUMAN PROTEASE PROTEINS, NUCLEIC ACID MOLECULES ENCODING HUMAN PROTEASE PROTEINS, AND USES THEREOF